Stocks and Investing Stocks and Investing
Tue, October 3, 2023
[ 12:00 AM ] - WOPRAI
Josh Sullivan Reiterated (SPR) at Strong Buy and Held Target at $45 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Bascome Majors Maintained (CSX) at Hold with Decreased Target to $33 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (CWEN) at Hold with Decreased Target to $23 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Greg Barnes Maintained (CCJ) at Buy with Increased Target to $70 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jamie Rollo Maintained (CCL) at Sell with Decreased Target to $11 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
David Vogt Initiated (CDW) at Strong Buy and Held Target at $237 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Aleksey Yefremov Maintained (CE) at Buy with Increased Target to $150 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Pavel Molchanov Upgraded (CLNE) to Strong Buy and Held Target at $6 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Aleksey Yefremov Upgraded (WLK) to Hold on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Batya Levi Upgraded (WMG) to Strong Buy and Increased Target to $37 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Andy Barish Upgraded (WING) to Hold and Increased Target to $170 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jake Bartlett Reiterated (WING) at Hold and Held Target at $191 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Mark Mahaney Upgraded (WRBY) to Buy and Held Target at $20 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Bascome Majors Maintained (WERN) at Hold with Decreased Target to $42 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Richard Anderson Initiated (WELL) at Hold and Held Target at $83 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Patrick Walravens Reiterated (WDAY) at Buy and Held Target at $260 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AY) at Hold with Decreased Target to $22 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Betsy Graseck Maintained (AXP) at Buy with Decreased Target to $185 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Ronald Epstein Upgraded (BAH) to Strong Buy and Increased Target to $130 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Betsy Graseck Maintained (BAC) at Hold with Decreased Target to $32 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Matthew Akers Maintained (BA) at Buy with Decreased Target to $230 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Anthony Crowdell Initiated (AWK) at Strong Buy and Held Target at $134 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Yuan Zhi Reiterated (ATNM) at Strong Buy and Held Target at $20 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Richard Anderson Initiated (AVB) at Hold and Held Target at $179 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Mark Delaney Maintained (AUR) at Hold with Decreased Target to $2.5 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Ken Newman Initiated (ZBRA) at Hold on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Nicholas Zangler Maintained (ADEA) at Buy with Decreased Target to $16 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Gavin Clark-Gartner Initiated (ACRS) at Buy and Held Target at $22 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Pavel Molchanov Maintained (BE) at Buy with Decreased Target to $20 on, Oct 3rd, 2023
[ 12:00 AM ] - WOPRAI
Emily Bodnar Maintained (BCTX) at Strong Buy with Decreased Target to $20 on, Oct 3rd, 2023

Emily Bodnar Maintained (BCTX) at Strong Buy with Decreased Target to $20 on, Oct 3rd, 2023


Published on 2024-10-28 06:40:49 - WOPRAI, Emily Bodnar
  Print publication without navigation


Emily Bodnar of HC Wainwright & Co., Maintained "BriaCell Therapeutics Corp." (BCTX) at Strong Buy with Decreased Target from $25 to $20 on, Oct 3rd, 2023.

Emily, nor any peers, have made any analyst calls on BCTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources